NMRD.US Nemaura Medical Inc

Healthcare Health Care Equipment & Supplies USA Stocks
0.0001 USD
Close of Nov 15, 2026
Market cap
USD 4.04K
P/E
-
P/B
122.56x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Dec 2023.

Is NMRD.US undervalued?

Graham number

The Graham number of Nemaura Medical Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nemaura Medical Inc fundamental analysis

No fundamental analysis for Nemaura Medical Inc yet.

Nemaura Medical Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nemaura Medical Inc

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and re…

Full company profile